Coronary stents (CS) are expandable tubular metallic devices, which are introduced into coronary arteries, when the arteries are clogged due to an underlying atherosclerosis disease. This revascularization procedure is termed as a percutaneous coronary intervention (PCI) or coronary angioplasty with stent placement.
The coronary stent was first developed in the 1980s, and has continued to evolve in terms of shape, structure, and the material used within them.
Market Dynamics
Increasing product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, in December 2021, Svelte Medical, which is a privately-held company, dedicated to redefining the approach to coronary stenting, announced the U.S. Food and Drug Administration (FDA) approval for SLENDER Sirolimus-Eluting Coronary Stent Integrated Delivery System and DIRECT Sirolimus-Eluting Coronary Stent Rapid Exchange Delivery System, which is intended for use in patients who have a narrowing in their coronary arteries.
The increasing prevalence of coronary heart diseases is expected to drive the market growth over the forecast period. For instance, in October 2022, according to an article published by Centers for Disease Control and Prevention (CDC), stated that heart disease is the leading cause of death in the U.S. and about 20.1 million adults age 20 and older in the U.S. have Coronary Artery Disease (CAD).
Key features of the study:
- This report provides in-depth analysis of the global coronary stents market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global coronary stents market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study Medtronic, iVascular, Alvimedica, Alta Biomaterials, Japan Medical Device Technology Co., Ltd., Veritas Bioventions Pvt Ltd, Nano Therapeutics Pvt. Ltd, Abbott, SLTL Group, Translumina Therapeutics LLP, DSM, Arterius, Terumo Corporation, SMT, Boston Scientific Corporation, Cook, Biotronik, B. Braun SE, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd, C. R. Bard, Inc, KYOTO MEDICAL PLANNING Co., Ltd, QualiMed, Elixir Medical Corporation, ENDOCOR GmbH & CO. KG, Amaranth Medical, Inc.
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global coronary stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global coronary stents market
Detailed Segmentation:
- Global Coronary Stents Market, By Product Type:
- Bare-Metal Stents
- Drug Eluting Stents
- Bioabsorbable Stents
- Global Coronary Stents Market, By Material:
- Metallic
- Stainless Steel
- Silicon Carbide
- Titanium Nitride Oxide
- Cobalt Chromium
- Platinum Chromium
- Others
- Polymeric
- Non-degradable/Permanent Stents
- Degradable/Temporary Stents
- Global Coronary Stents Market By End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- Global Coronary Stents Market, By Region:
- North America
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Medtronic.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- iVascular
- Alvimedica
- Alta Biomaterials
- Japan Medical Device Technology Co., Ltd.
- Veritas Bioventions Pvt Ltd
- Nano Therapeutics Pvt. Ltd
- Abbott
- SLTL Group
- Translumina Therapeutics LLP
- DSM
- Arterius
- Terumo Corporation
- SMT
- Boston Scientific Corporation
- Cook
- Biotronik
- B. Braun SE
- MicroPort Scientific Corporation
- Meril Life Sciences Pvt. Ltd
- C. R. Bard, Inc.
- KYOTO MEDICAL PLANNING Co., Ltd
- QualiMed
- Elixir Medical Corporation
- ENDOCOR GmbH & CO. KG
- Amaranth Medical, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
